10-K Filing

AIM IMMUNOTECH INC. CIK: 946644 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001493152-24-012058`
Period End Date	20231231
Filing Date	20240401
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	form10-k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 110 Income Statement 68 Cash Flow Statement 128 Stockholders Equity 30

Balance Sheet 110 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$27.05M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$27.05M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.44M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$7.63M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$7.63M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$7.14M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$7.14M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableNetCurrent`	$1.18M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableNetCurrent`	$1.18M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableNetCurrent`	$1.68M	USD	Point-in-time
Funds receivable from New Jersey net operating loss	`AccountsReceivableNetCurrent`	$1.68M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$455.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$455.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$302.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$302.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$36.32M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$36.32M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$14.56M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$14.56M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	48.08M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	48.08M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	49.10M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	49.10M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$195.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$195.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$127.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$127.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	48.08M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	48.08M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$829.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$829.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$697.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$697.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	49.10M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	49.10M	shares	Point-in-time
Unvested stock awards	`SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares`	701,667.00	shares	Point-in-time
Unvested stock awards	`SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares`	701,667.00	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.31M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.31M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.94M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.94M	USD	Point-in-time
Unvested stock awards	`SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares`	694,324.00	shares	Point-in-time
Unvested stock awards	`SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares`	694,324.00	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.20M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.20M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.69M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.69M	USD	Point-in-time
Total assets	`Assets`	$40.49M	USD	Point-in-time
Total assets	`Assets`	$40.49M	USD	Point-in-time
Total assets	`Assets`	$19.38M	USD	Point-in-time
Total assets	`Assets`	$19.38M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$377.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$377.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.44M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.44M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.99M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.99M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$806.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$806.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$178.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$178.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$223.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$223.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.65M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.65M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.36M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.36M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$659.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$659.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$495.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$495.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$2.02M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.02M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.15M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.15M	USD	Point-in-time
Commitments and contingencies (Notes 8, 10, 11, 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 8, 10, 11, 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 8, 10, 11, 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 8, 10, 11, 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 49,102,484 and 48,084,287 (including 701,667 and 694,324 of unvested stock awards) as of December 31, 2023 and 2022, respectively	`CommonStockValue`	$48.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 49,102,484 and 48,084,287 (including 701,667 and 694,324 of unvested stock awards) as of December 31, 2023 and 2022, respectively	`CommonStockValue`	$48.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 49,102,484 and 48,084,287 (including 701,667 and 694,324 of unvested stock awards) as of December 31, 2023 and 2022, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 49,102,484 and 48,084,287 (including 701,667 and 694,324 of unvested stock awards) as of December 31, 2023 and 2022, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$418.27M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$418.27M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$419.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$419.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-380.55M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-380.55M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-409.51M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-409.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$56.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$56.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$38.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$38.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.23M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.23M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$19.38M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$19.38M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$40.49M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$40.49M	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$202.00K	USD	Annual
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$202.00K	USD	Annual
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$141.00K	USD	Annual
Clinical treatment programs US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$141.00K	USD	Annual
Total Revenues	`Revenues`	$141.00K	USD	Annual
Total Revenues	`Revenues`	$141.00K	USD	Annual
Total Revenues	`Revenues`	$202.00K	USD	Annual
Total Revenues	`Revenues`	$202.00K	USD	Annual
Production costs	`ManufacturingCosts`	-	USD	Annual
Production costs	`ManufacturingCosts`	-	USD	Annual
Production costs	`ManufacturingCosts`	$42.00K	USD	Annual
Production costs	`ManufacturingCosts`	$42.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$10.94M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$10.94M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$6.99M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$6.99M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$13.07M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$13.07M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$21.14M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$21.14M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$32.12M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$32.12M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$20.06M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$20.06M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-31.92M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-31.92M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-19.92M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-19.92M	USD	Annual
Gain (loss) on investments	`GainLossOnInvestments`	$200.00K	USD	Annual
Gain (loss) on investments	`GainLossOnInvestments`	$200.00K	USD	Annual
Gain (loss) on investments	`GainLossOnInvestments`	$-1.68M	USD	Annual
Gain (loss) on investments	`GainLossOnInvestments`	$-1.68M	USD	Annual
Interest and other income	`OtherNonoperatingIncomeExpense`	$629.00K	USD	Annual
Interest and other income	`OtherNonoperatingIncomeExpense`	$629.00K	USD	Annual
Interest and other income	`OtherNonoperatingIncomeExpense`	$1.07M	USD	Annual
Interest and other income	`OtherNonoperatingIncomeExpense`	$1.07M	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$18.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$18.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$3.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$3.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-35.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-35.00K	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-1.67M	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-1.67M	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-1.49M	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLoss`	$-1.49M	USD	Annual
Net Loss	`NetIncomeLoss`	$-28.96M	USD	Annual
Net Loss	`NetIncomeLoss`	$-28.96M	USD	Annual
Net Loss	`NetIncomeLoss`	$-19.45M	USD	Annual
Net Loss	`NetIncomeLoss`	$-19.45M	USD	Annual
Basic loss per share	`EarningsPerShareBasic`	$-0.40	USD	Annual
Basic loss per share	`EarningsPerShareBasic`	$-0.40	USD	Annual
Basic loss per share	`EarningsPerShareBasic`	$-0.60	USD	Annual
Basic loss per share	`EarningsPerShareBasic`	$-0.60	USD	Annual
Diluted loss per share	`EarningsPerShareDiluted`	$-0.40	USD	Annual
Diluted loss per share	`EarningsPerShareDiluted`	$-0.40	USD	Annual
Diluted loss per share	`EarningsPerShareDiluted`	$-0.60	USD	Annual
Diluted loss per share	`EarningsPerShareDiluted`	$-0.60	USD	Annual
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesIssuedBasic`	48.05M	shares	Annual
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesIssuedBasic`	48.05M	shares	Annual
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesIssuedBasic`	48.59M	shares	Annual
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesIssuedBasic`	48.59M	shares	Annual
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.59M	shares	Annual
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.59M	shares	Annual
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.05M	shares	Annual
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.05M	shares	Annual

Cash Flow Statement 128 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-28.96M	USD	Annual
Net loss	`NetIncomeLoss`	$-28.96M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.45M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.45M	USD	Annual
Depreciation of property and equipment	`Depreciation`	$38.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$38.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$39.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$39.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-35.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-35.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	$18.00K	USD	Annual
Gain on sale of fixed assets	`GainLossOnDispositionOfAssets1`	$18.00K	USD	Annual
Abandonment and expiration of patents and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	$14.00K	USD	Annual
Abandonment and expiration of patents and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	$14.00K	USD	Annual
Abandonment and expiration of patents and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	-	USD	Annual
Abandonment and expiration of patents and trademark rights	`AbandonmentOfPatentAndTrademarkRights`	-	USD	Annual
Amortization of patent and trademark rights	`AmortizationOfIntangibleAssets`	$199.00K	USD	Annual
Amortization of patent and trademark rights	`AmortizationOfIntangibleAssets`	$199.00K	USD	Annual
Amortization of patent and trademark rights	`AmortizationOfIntangibleAssets`	$218.00K	USD	Annual
Amortization of patent and trademark rights	`AmortizationOfIntangibleAssets`	$218.00K	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$287.00K	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$287.00K	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$-680.00K	USD	Annual
Non-cash lease expense	`NoncashLeaseExpense`	$-680.00K	USD	Annual
Loss from sale of income tax operating losses	`LossGainFromSaleOfIncomeTaxOperatingLosses`	-	USD	Annual
Loss from sale of income tax operating losses	`LossGainFromSaleOfIncomeTaxOperatingLosses`	-	USD	Annual
Loss from sale of income tax operating losses	`LossGainFromSaleOfIncomeTaxOperatingLosses`	$-197.00K	USD	Annual
Loss from sale of income tax operating losses	`LossGainFromSaleOfIncomeTaxOperatingLosses`	$-197.00K	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$954.00K	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$954.00K	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$243.00K	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$243.00K	USD	Annual
Loss (gain) on sale of marketable investments	`MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments`	$-1.68M	USD	Annual
Loss (gain) on sale of marketable investments	`MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments`	$-1.68M	USD	Annual
Loss (gain) on sale of marketable investments	`MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments`	$200.00K	USD	Annual
Loss (gain) on sale of marketable investments	`MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments`	$200.00K	USD	Annual
Funds receivable from New Jersey operating loss sales	`IncreaseDecreaseInAccountsReceivable`	$-492.00K	USD	Annual
Funds receivable from New Jersey operating loss sales	`IncreaseDecreaseInAccountsReceivable`	$-492.00K	USD	Annual
Funds receivable from New Jersey operating loss sales	`IncreaseDecreaseInAccountsReceivable`	$35.00K	USD	Annual
Funds receivable from New Jersey operating loss sales	`IncreaseDecreaseInAccountsReceivable`	$35.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$151.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$151.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-153.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-153.00K	USD	Annual
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-274.00K	USD	Annual
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-274.00K	USD	Annual
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$688.00K	USD	Annual
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$688.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$83.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$83.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$486.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$486.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$179.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$179.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.07M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$6.07M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.18M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.18M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$368.00K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$368.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.11M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.11M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.27M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.27M	USD	Annual
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$1.30M	USD	Annual
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$1.30M	USD	Annual
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$10.08M	USD	Annual
Proceeds from sale of marketable investments	`ProceedsFromSaleOfInvestmentProjects`	$10.08M	USD	Annual
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$2.72M	USD	Annual
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$2.72M	USD	Annual
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$1.59M	USD	Annual
Purchase of marketable investments	`PaymentsToAcquireInvestments`	$1.59M	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$86.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$86.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$47.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$47.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$3.90M	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$3.90M	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$185.00K	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$185.00K	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$585.00K	USD	Annual
Purchase of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$585.00K	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$10.99M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$10.99M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-832.00K	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-832.00K	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$80.00K	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$80.00K	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$485.00K	USD	Annual
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$485.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$485.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$485.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$80.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$80.00K	USD	Annual
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-5.04M	USD	Annual
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-5.04M	USD	Annual
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-21.61M	USD	Annual
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-21.61M	USD	Annual
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$32.09M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$27.05M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Unrealized gain (loss) on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$-928.00K	USD	Annual
Unrealized gain (loss) on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$-928.00K	USD	Annual
Unrealized gain (loss) on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$376.00K	USD	Annual
Unrealized gain (loss) on marketable investments	`UnrealizedGainLossOnMarketableInvestments`	$376.00K	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$7.00K	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$7.00K	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$19.00K	USD	Annual
Conversion of Series B preferred	`ConversionOfSeriesBPreferred`	$19.00K	USD	Annual
Operating lease liability arising from obtaining right of use asset	`OperatingLeaseLiabilityArisingFromObtainingRightOfUseAsset`	$73.00K	USD	Annual
Operating lease liability arising from obtaining right of use asset	`OperatingLeaseLiabilityArisingFromObtainingRightOfUseAsset`	$73.00K	USD	Annual
Operating lease liability arising from obtaining right of use asset	`OperatingLeaseLiabilityArisingFromObtainingRightOfUseAsset`	$736.00K	USD	Annual
Operating lease liability arising from obtaining right of use asset	`OperatingLeaseLiabilityArisingFromObtainingRightOfUseAsset`	$736.00K	USD	Annual

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$56.88M	USD	Point-in-time
Balance	`StockholdersEquity`	$56.88M	USD	Point-in-time
Balance	`StockholdersEquity`	$38.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$38.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$80.00K	USD	Annual
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$80.00K	USD	Annual
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$485.00K	USD	Annual
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$485.00K	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$243.00K	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$243.00K	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$954.00K	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$954.00K	USD	Annual
Series B preferred shares converted to common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Series B preferred shares converted to common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Series B preferred shares converted to common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Series B preferred shares converted to common shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-28.96M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-28.96M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-19.45M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-19.45M	USD	Annual
Cashless warrant conversion	`CashlessWarrantConversion`	-	USD	Annual
Cashless warrant conversion	`CashlessWarrantConversion`	-	USD	Annual
Balance	`StockholdersEquity`	$56.88M	USD	Point-in-time
Balance	`StockholdersEquity`	$56.88M	USD	Point-in-time
Balance	`StockholdersEquity`	$38.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$38.47M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.